Roche announces new data for risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress

Roche today announced interim clinical data from the dose-finding parts of the pivotal FIREFISH and SUNFISH studies investigating risdiplam (RG7916) in SMA.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news